Table 4.
Elevated VOCs† | Lung cancers vs. Healthy individuals |
|
---|---|---|
Ad-OR (95% CI) | P values | |
Acetaldehyde | 1.79 (1.20–2.66) | 0.002 |
2-Hydroxyacetaldehyde | 1.99 (1.35–2.92) | <0.001 |
Isoprene | 20.5 (12.6–33.3) | <0.001 |
Pentanal | 8.55 (5.60–13.0) | <0.001 |
Butyric acid | 2.06 (1.38–3.07) | <0.001 |
Toluene | 8.24 (5.12–13.3) | <0.001 |
2,5-Dimethylfuran | 8.15 (5.07–13.1) | <0.001 |
Cyclohexanone | 2.86 (1.94–4.22) | <0.001 |
Hexanal | 20.8 (12.4–35.1) | <0.001 |
Heptanal | 5.07 (3.32–7.73) | <0.001 |
Acetophenone | 5.05 (3.24–7.86) | <0.001 |
Propylcyclohexane | 7.31 (4.77–11.2) | <0.001 |
Octanal | 3.64 (2.40–5.51) | <0.001 |
Nonanal | 8.63 (5.64–13.2) | <0.001 |
Decanal | 4.45 (2.98–6.63) | <0.001 |
2,2-Dimethyldecane | 7.17 (4.74–10.8) | <0.001 |
Adjusted confounding factors: age, gender, smoking history, alcohol history, diabetes, and cardiovascular diseases.
Multivariate logistic regression models with the backward conditional methods were used.
Elevated VOC was defined as peak intensity over the up tertiles.
Ad-OR: adjusted odds ratio; CI: confidence interval.